FDA will reconsider decision barring copycat versions of Lilly weight loss drug

The Hill - Oct 14, 2024

The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and diabetes drug from its official shortage list and allow compounding pharmacies to continue selling their own versions. A federal court in Texas on Friday granted the FDA’s unopposed motion to stay litigation over the drug’s...

Read full article

More News


ABOUT US

Today’s rapid pace of information flow requires news to keep up in real time. We bring innovation to digital news for you to keep abreast of worldwide news instantly.


Copyright © 2015 - 2026 The World Agenda. All Rights Reserved.